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Objectives: Air pollution contributes to mortality and morbidity. We estimated the impact of outdoor air pollution
on public health in Seoul metropolitan area, Korea. Attributable cases of morbidity and mortality were estimated.
Methods: Epidemiology-based exposure-response functions for a 10 μg/m3 increase in particulate matter (PM2.5
and PM10) were used to quantify the effects of air pollution. Cases attributable to air pollution were estimated
for mortality (adults ≥ 30 years), respiratory and cardiovascular hospital admissions (all ages), chronic bronchitis
(all ages), and acute bronchitis episodes (≤18 years). Environmental exposure (PM2.5 and PM10) was modeled for
each 3 km × 3 km.
Results: In 2010, air pollution caused 15.9% of total mortality or approximately 15,346 attributable cases per year.
Particulate air pollution also accounted for: 12,511 hospitalized cases of respiratory disease; 20,490 new cases of
chronic bronchitis (adults); 278,346 episodes of acute bronchitis (children). After performing the 2nd Seoul
metropolitan air pollution management plan, the reducible death number associated with air pollution is 14,915
cases per year in 2024. We can reduce 57.9% of death associated with air pollution.
Conclusion: This assessment estimates the public-health impacts of current patterns of air pollution. Although
individual health risks of air pollution are relatively small, the public-health consequences are remarkable. Particulate
air pollution remains a key target for public-health action in the Seoul metropolitan area. Our results, which
have also been used for economic valuation, should guide decisions on the assessment of environmental
health-policy options.
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Urbanization and industrialization are ongoing world-
wide. Air pollution accompanied by urbanization and
industrialization has already become a major risk factor
threatening human health. Fine PM (PM2.5) air pollution
and mortality were linked in the Six Cities Study, which
reported an association between PM2.5 and all cause,
cardiopulmonary, and lung cancer mortality [1,2].
Research conducted during the past 20 years in the
US, EU, and Asian countries has confirmed that outdoor
air pollution contributes to morbidity and mortality [3-5].* Correspondence: ekeeper@inha.ac.kr
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unless otherwise stated.Some effects may be related to short-term exposure [6,7],
others have to be considered as contributions of long-
term exposure. Although the mechanisms have not been
fully explained, epidemiological evidence suggests that
outdoor air pollution is a contributing cause of morbid-
ity and mortality [8].
The recent Global Burden of Disease report estimated
that 89% of the world’s population lived in areas with
PM2.5 ambient levels above the World Health Organization
(WHO) Air Quality Guideline of 10 μg/m3, and 32% lived
in areas above the WHO Level 1 Interim Target of 35 μg/
m3. East Asia was singled out, with an estimated 76%
population exposure above the Level 1 Interim Target [9].
In 1998, the average PM10 concentration in Seoul
was 78 μg/m3. According to the first metropolitan airhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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tration in Seoul was 41 μg/m3 in 2012 [10]. Even with a
dramatic decrease of PM10, the current level of PM10 still
exerts a significant burden of disease on people in Korea.
The Korean government established the 2nd metropol-
itan air pollution management plan during 2015–2024.
In this plan, the goal of air quality is that PM10 reach
30 μg/m3 and PM2.5 reach 20 μg/m3.
Assessing public health benefit can be possible by risk
assessment of air pollution. Up to now, public health as-
sessment are not performed in Korea for monitoring air
quality. In this study, we will assess public health benefit
by calculating mortality and morbidity cases attributed
to air pollution in the Seoul metropolitan area.
Methods
Design and participants
The impact assessment relies on calculating the attrib-
utable number of cases [11,12]. Cases of morbidity or




Death rate, excluding violent death












ICD9 410–414, 426–429, 434–440
Lung cancer incidence ICD9 162
Asthma attack (children
< 15 years)
Lower respiratory symptoms, age
6–12 years
Asthma, age 7–15 years




Wheeze, age 18–80 years
Shortness of breath, age 18–55 years
Wheeze, age 16–70 years
Chronic-bronchitis Symptoms of cough and/or sputum
production on most days, for at least




Bronchitis in past 12 months, ages
less than 18 years.the health outcomes listed in Table 1. Outcomes were
ignored if quantitative data were not available, if costing
was impossible (e.g., valuing decrement in pulmonary
function), and to prevent overlapping health measures
from causing multiple counting of the same costs (e.g.,
emergency visits were not considered because they were
partly included in the hospital admissions). We selected
only PM2.5 or PM10 in order to derive the attributable
cases because PM2.5 and PM10 are useful indicators of
several sources of outdoor air pollution such as fossil-
fuel combustion. Three data components are required
for estimation of the number of cases attributed to out-
door air pollution in a given population: the exposure-
response function; the frequency of the health outcome
(e.g., the incidence or prevalence) and the level of ex-
posure. The association between outdoor air pollution
and health-outcome frequency is usually described with
an exposure-response function (or effect estimate) that
expresses the relative increase in adverse health for a
given increment in air pollution.Source of exposure-response
function
Source of population frequency
Dockery DW et al. [1]
National death certificate statistics
for 2010 and 2024(prediction)
(adults _30 years)
Pope CA et al. [2]
Pope CA et al. [15]
Pope CA et al. [16] National population statistics for
2010 and 2024(prediction)Spix C et al. [17]
Wordley J et al. [18]
Prescott GJ et al. [19]
Wordley J et al. [18] National population statistics for
2010 and 2024(prediction)Poloniecki JD et al. [20]
Medina S et al. [21]
Prescott GJ et al. [19]
Raaschou-Nielsen O et al. [26]
Roemer W et al. [27] National population statistics for
2010 and 2024(prediction)
Segala C et al. [28]
Gielen MH et al. [29]
Dusseldorp A et al. [30] National population statistics for
2010 and 2024(prediction)
Hiltermann TJN et al. [31]
Neukirch F et al. [32]
Abbey D et al. [22] National population statistics for
2010 and 2024(prediction)
Dockery DW et al. [23] National population statistics for
2010 and 2024(prediction)
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Population data for the Seoul metropolitan area from
Statistics Korea is classified according to address and
registration in the following age groups: 0–4, 5–9, 10–
14, 15–19, 20–24, 25–29, 30–34, 35–39, 40–44, 45–49,
50–54, 55–59, 60–64, and 65+ years. Citizens’ residences
in the Seoul metropolitan area were divided into 80 sec-
tions according to neighborhoods, forming basic admin-
istrative units such as Gu and Gun, used in city planning
and management. Eighty sections were formed in order
to identify site-specific exposure to air pollution and
identify the areas with the greatest risk. 2024 population
data were obtained from population prediction data of
Statistics Korea. The health outcome definition and
source of data are listed in Table 1. The total regional
baseline mortality was retrieved from statistics on Korea
(International Classification of Diseases–ICD-10, A00-
Y98). ICD-9 code in previous studies were translated
into ICD10. The morbidity calculations were performed
using hospitalization data from the Korean Health In-
surance, which covers the entire population and is the
sole purchaser of health care services in the country.
Hospitalizations due to two main disease groups were
included in the calculations: cardiovascular (I00-I99)
and respiratory causes (J00-J99). Cardiac admissions
(I20-I25) and cerebrovascular admissions (I60-I69) were
also used for the exposure-response work on cardiovas-
cular hospitalizations.
Exposure assessment
CMAQ (Comprehensive Multiscale Air Quality) [13]
version 4.7.1 was used to simulate air quality over the
Seoul Metropolitan Area (SMA) for a one-month period
of each season in 2010and 2024; January, April, July, and
October. The Nesting-down domains were composed of
27-km, 9-km, and 3-km horizontally resolved domains.
The coarse domain (174x128 arrays) includes northeast-
ern Asia; Korea, Japan, and most of China. The 9-km
domain (67x82 arrays) includes all of South Korea and
most of North Korea, and the finest domain (58x61 ar-
rays) was set up to focus on the SMA. The SAPRC-99
(Statewide Air Pollution Research Center 99) [14] chem-
ical mechanism for gas-phase chemistry and AERO5 for
aerosol module were selected to represent model species
over the region.
For meteorological simulation, WRF (Weather Research
and Forecast) version 3.4.1 was utilized with NCEP (Na-
tional Centers for Environmental Prediction) Final (FNL)
Operational Global Analysis Model fields for initial and
boundary conditions [13]. The WRF was configured to
have 35 sigma layers up to 50 hpa, and the lowest layer
thickness is around 30 m (sigma = 0.996). The WRF
physical options are as follows: WRF Single-Moment 6-
class scheme, Rapid Radiative Transfer Model longwavescheme, Goddard shortwave scheme, M-O surface layer
scheme, Grell Cumulus scheme, and YSU PBL scheme.
Meteorology-Chemistry Interface Program (MCIP) ver-
sion 3.6 was then used for preparation of CMAQ-ready
meteorological inputs. One-way nesting was applied
during WRF and CMAQ simulations.
The CAPSS 2010 (Clean Air Protection Supporting
System, 2010 base year), anthropogenic emissions in-
ventory, was processed using SMOKE (Sparse Matrix
Operation Kernel Emission) version 3.1, and biogenic
emissions such as isoprene and terpenes were estimated
using MEGAN (Model of Emissions of Gases and Aerosols
from Nature) [15] version 2.04. The MICS-Asia emissions
inventory was supplementary used for foreign emissions.
Exposure-response functions, calculation of mortality and
morbidity
To describe the long-term effect of air pollution on mortal-
ity, the broadly employed US ACS study relative risk RR =
1.06 (95% CI 1.02–1.11) per 10 μg/m3 increase of PM2.5
was used as the exposure-response relationship [16].
RR = 1.013 (95% CI 1.001–1.025) per 10 μg/m3 increase
of PM10 was used for calculations of respiratory hospitali-
zations due to air pollution [17-20]. For cardiovascular
hospitalizations we used a weighted average RR = 1.013
(95% CI 1.007–1.019) per 10 μg/m3 increase of PM10
based on the effect on cardiac and cerebrovascular admis-
sions from a COMEAP meta-analysis [21,22]. For chronic
bronchitis incidence, we used RR = 1.098 (95% CI 1.009–
1.194) per 10 μg/m3 increase of PM10 based on one study,
which reported the effect of PM on the incidence of
chronic bronchitis among a population with very low rates
of smoking [23].
For bronchitis episodes, we used RR = 1.306 (95% CI
1.135–1.502) per 10 μg/m3 increase of PM10 validated at
several studies [24-26]. The meta-analyses showed a sta-
tistically significant association between risk of lung can-
cer and PM10 (hazard ratio [HR] 1 · 22 [95% CI 1 · 03-1 ·
45] per 10 μg/m3 [27]. For asthma attacks that occurred
in children younger than 15 years old, we used RR =
1.044 (95% CI 1.027–1.062) per 10 μg/m3 increase of
PM10 [28-30]. For asthma attacks that occurred in adults
older than 15 years old, we used RR = 1.039 (95% CI
1.019–1.059) per 10 μg/m3 increase of PM10 [31-33]. The
cases (mortality and morbidity) were calculated in abso-
lute and relative numbers for all sections in the Seoul
Metropolitan area. The following equation was used:




where Y0 is the baseline rate; pop the number of exposed
persons; · the exposure-response function and △PM2.5 the
estimated excess exposure.
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reviewed literature in order to derive the exposure-
response function and the 95% CI. For inclusion, an
adequate study design and published PM10 levels were
required. Cross-sectional or cohort studies relying on
two or three levels of exposure were omitted, as were
ecological studies, given their inherent limitations. The
health-outcome frequencies (mortality, prevalence, inci-
dence, or person-days) may differ across countries; thus,
national mortality and morbidity data were used (Table 2).
For some morbidity data, epidemiological studies were the
only source (bronchitis incidence from the Adventist
Health and Smog Study [34], which was also used by
Ostro and colleagues [35]. Annual mean outdoor PM10
had to be determined on a continuous scale. Although
there is no evidence for any threshold, there are also no
studies available where participants were exposed to
PM10 below 20 μg/m3 (annual mean). This reference
level also includes the natural background PM10. Thus,
the health impact of air-pollution exposure below 20 μg/
m3 was ignored. To derive the population exposure distri-
bution, mean annual concentrations of PM10 were mod-
elled for each area at a spatial resolution of 3 km× 3 km.
Using the exposure-response functions, expressed as rela-
tive risk (RR) per 10 μg/m3, and the health frequency per
1000 000 inhabitants, for each health outcome we calcu-
lated the attributable number of cases (D10) for an increase
of 10 μg/m3 PM10, as: D10 = (RR-1)*P0 where P0 is the
health frequency, given an baseline exposure E0 and RR is
the mean exposure-response function across the studies
used (Table 1). The exposure-response functions are usu-
ally log-linear. For small risks and across limited ranges ofTable 2 Effect estimate of health outcome and health
outcome frequencies
Health Outcome Effect estimate
relative risk (95% CI)






Adult age ≥ 30
1 · 06 (1 · 02–1 · 11)* 5,950
Respiratory hospital
admissions (All age)
1 · 013 (1 · 001–1 · 025) 15,630
Cadiovascular hospital
admissions (All age)
1 · 013 (1 · 007–1 · 019) 15,430
Lung cancer incidence 1 · 22 (1 · 03-1 · 45) 287
Asthma attack (children
< 15 years)
1 · 044 (1 · 027–1 · 062) 19,930
Asthma attack (adults ≥
15 years)
1 · 039 (1 · 019–1 · 059) 24,570
Chronic-bronchitis
(adults 25 years)
1 · 098 (1 · 009–1 · 194) 4,990
Acute bronchitis
(age ≤ 18)
1 · 306 (1 · 135–1 · 502) 100,720
*per 10 μg/m3 PM2.5.exposure log-linear and linear functions would provide simi-
lar results. However, if one may apply the method to popula-
tions with very large exposure ranges, the impact may be
seriously overestimated on the log-linear scale. Thus, we de-
rived the attributable number of cases on an additive scale.
The study protocol was approved by the Institutional Review
Boards of the Inha University College of Medicine.
Results
Table 2 summarizes the effect estimates, the specific
health-outcome frequencies at E0, and the respective num-
ber of cases attributable to a 10 μ/m3 increase in PM10
(D10) for each health outcome. A summary of health out-
comes attributed to particulate air pollution in the Seoul
metropolitan area is shown in Table 3. The number of
cases attributable to air pollution is given for three scenar-
ios; year 2010, year 2024 without regulation regarding air
pollution, year 2024, when the goal of air attainment is
achieved. PM2.5 concentrations without reducing air emis-
sions in 2024 are shown in Figure 1. PM2.5 concentrations
after reducing air emissions in 2024 are shown in Figure 2.
We compared the number of cases attributed to air pol-
lution for three scenarios. We drew flow chart of this
study (Figure 3).
Air pollution caused 15.9% of total mortality or approxi-
mately 15,346 attributable cases per year in 2010. Particu-
late air pollution also accounted for: 12,511 hospitalized
cases of respiratory disease; 20,490 new cases of chronic
bronchitis (adults); 278,346 episodes of acute bronchitis
(children). After performing the 2nd Seoul metropolitan
air pollution management plan, Air pollution caused 6.7%
of total mortality or approximately 10,866 attributable
cases per year in 2024.
Discussion
The public-health impact depends not only on the relative
risk but also on the exposure distribution in the popula-
tion. Our assessment assigned approximately 15.9% of an-
nual deaths to outdoor air pollution. Our assessment is
relatively high compared to 6% of EU’s assessment [12].
Korean people have high chronic disease incidences of
cancer and chronic respiratory diseases, such as asthma
and COPD [36]. According to OECD Health data [37], in
2009, the hospital admission rate for avoidable asthma in
the population age 15 and over was 101.5/100,000 per-
sons, while average OECD was 51.8/100,000 persons. In
2009, the hospital admission rate for COPD in the popula-
tion age 15 and over was 222/100,000 persons, while aver-
age OECD was 198/100,000 persons. The incidence rate
for all cancers combined in Korea showed an annual
increase of 3.3% from 1999 to 2009 [38]. Considering
current air pollution levels and our study’s results, cer-
tainly air pollution has important contribution to in-
creases of cancer and chronic respiratory diseases in
Table 3 Health outcome attributed to particulate air pollution in Seoul metropolitan area











95% CI 95% CI 95% CI
Premature deaths /persons/year) 15,346 (4,498 ~ 26,242) 25,781 (7,555 ~ 44,098) 10,866 (3,280 ~ 18,081) 14,915 (57.9%∇)
Respiratory hospital admissions
(All age)
12,511 (956 ~ 23,583) 14,163 (1,114 ~ 26,701) 7,837 (611 ~ 14,865) 6,326 (44.7%∇)
Cardiovascular hospital admissions
(All age)
12,351 (6,715 ~ 17,868) 13,982 (7,602 ~ 20,229) 7,736 (4,193 ~ 11,227) 6,246 (44.7%∇)
Lung cancer incidence 1,403 (254 ~ 2,170) 1,590 (287 ~ 2,462) 962 (159 ~ 1,613) 628 (45.2%∇)
Asthma attack (children < 18 years) 11,389 (7,180 ~ 15,601) 9,745 (6,143 ~ 13,350) 5,563 (3477 ~ 7,688) 4,182 (42.9%∇)
Asthma attack (adults ≥ 18 years) 44,006 (22,142 ~ 64,488) 53,300 (26,813 ~ 78,128) 29,789 (14,835 ~ 44,093) 23,511 (44.1%∇)
Chronic-bronchitis 20,490 (219 ~ 35,340) 24,836 (265 ~ 42,884) 14,276 (145 ~ 25,686) 10,560 (42.5%∇)
Acute bronchitis (age ≤ 18) 278,346 (153,949 ~ 360,290) 238,222 (131,744 ~ 313,483) 151,943 (78,491 ~ 212,851) 86,279 (36.2%∇)
Figure 1 PM2.5 concentration without reducing air emissions at 2024.
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Figure 2 PM2.5 concentration after reducing air emissions at 2024.
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tages. First, our study attempted to decrease uncertainty
inherent in these kinds of public health risk assessment.
To account for inherent uncertainty in the impact as-
sessment, an “at least” approach was applied for each
step, and the uncertainties in the effect estimates wereFigure 3 Flow chart of this study.quantified and the results were given as a range (95% CI
of the exposure-response function).
To assess the effects of air pollution—a complex mixture
of pollutants—epidemiological studies use several indica-
tors of exposure (e.g., NO2, CO, PM10, total suspended
particles, SO2). However, because these pollutants are
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observed effects to each pollutant. A pollutant-by-pollutant
assessment would grossly overestimate the impact. There-
fore, we selected only one pollutant to derive the attributed
cases.
The short-term effects of high pollution levels on mor-
tality were not calculated separately because these are
already included in exposure-response function of long-
term mortality. We consider it inappropriate to use short-
term studies for the impact assessment of annual mortality
[39]. Short-term studies capture only part of air-pollution-
related cases, namely those where exposure and event
(death) are closely connected in time. Our calculation
based on cohort studies captures both the short-term ef-
fects and the long-term effects. The number of deaths at-
tributed to air pollution would be about 4–5 times smaller
if the short-term effect estimates had been applied.
Second, we based our assumption on the consistency
of epidemiological results observed across many countries.
We derived exposure-response from selected well de-
signed studies used in previous public health assessment.
For mortality, we had to rely on two US studies, which
were confirmed by a third US study [40], French PAARC
study [41], China study [5]. Exposure-response used in
our study would be consistent because it was confirmed
across many countries.
Third, our study used nationwide frequency data.
Health-outcome frequencies may strongly influence the
impact assessment. Mortality from national sources may
be considered accurate. However, frequency measures
of morbidity and data on health-care systems have to be
considered estimates with some inherent uncertainties.
We selected national health frequency data in order to
reduce the impact of these limitations. National health
insurance covers almost all people in Korea, so that
health-outcome frequencies in our study have fewer in-
herent uncertainties.
However, our study has some limitations. First, our
assessment relies on some limited study for deriving
exposure-response functions. For chronic bronchitis, our
assessment relies on one study. The advantage of the
study is the reporting of effects of PM on the incidence
of chronic bronchitis among a population with very low
rates of smoking. This measure was particularly useful
for the economic valuation and had been used in other
studies [42]. Second, our study restricted the effect of air
pollution to PM10 and PM2.5, and did not take other pollut-
ants, such as NOx, SO2 and O3 into consideration. It can
underestimate independent effects of air pollution not ex-
plained by or correlated by PM fractions. Temperature is
increasing due to climate change. Ozone, showing higher
concentration these days, is expected to have more haz-
ardous effects on mortality in Korea and other countries
[43] than before. Our calculation regarding the effect ofair pollution may be underestimated, because we consider
the effect of PM only.
As we did not quantify the attributed number of
deaths below age 30 years, we might have underestimated
the real number of deaths attributed to air pollution. We
ignored potential effects on newborn babies or infants
[44]. Although infant mortality is low in Korea, and thus
the number of attributed cases is small, the impact on
years of life lost, and therefore the economic valuation,
could be considerable.
Third, we did not consider uncertainty in exposure as-
sessment. If we assume another exposure reference value,
the impact estimates will be higher. Our study assumed
that the health risk showed the least at PM10 exposure
level <20 μg/m3. In Korea, we have never experienced
PM10 exposure level <20 μg/m3. In other countries such
as EU and US, an exposure level of 15 μg/m3 corresponds
to the reference value in the public-health impact [45].
Our study can be underestimated because of our assump-
tion about the reference value.
Apart from the variability of epidemiological exposure-
response estimates (95% CI), we did not quantify other
sources of uncertainty, such as errors in the population
exposure distribution, or in the estimation of health out-
come frequencies. Simulations of multiple probability dis-
tributions may, however, erroneously suggest a level of
precision in assessing uncertainty that cannot be achieved.
These kinds of public health assessment contained a lot of
uncertainty. Our study took an “at least” approach in
order to account for inherent uncertainty in the impact
assessment. Our study insisted that the risk attributed to
air pollution in Korea at least exceeded our assessment.
Recent publication about air pollution study in Korea
focused on short-term effects of air pollution [46,47]. Re-
cently some studies report adverse pregnancy outcomes as-
sociated with air pollution from birth cohort study [48,49].
There is no report like this study in Korea. We assessed
public health benefit by calculating mortality and morbid-
ity cases attributed to air pollution in the Seoul metropol-
itan area.
Our study showed that air pollution had the significant
impact on the health of Korean people. In particular,
elderly people and children are the vulnerable popula-
tion to air pollution. In the valuation of air pollution
related death and hospitalization, assumptions about age
structure of those affected may be influential [47]. The
affected population will increase because of the rapidly
ageing population structure. Korea is a rapidly aging
society, and the number of elderly people older than
65 years is rapidly increasing. Actually the number of eld-
erly people older than 65 years in 2024 will be 12,635,000
persons and their portion will be 24.4% among all popula-
tion. Traffic is important contributor to urban air pollu-
tion in Korea and Asian countries. But traffic creates costs
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ternal costs from the Organization for Economic Cooper-
ation and Development (OECD) are quantified [50-53].
The traffic share of the total PM10 exposure depended on
the mean concentration, ranging from 28% at an annual
mean PM10 of 10–15 μg/m
3, and increasing up to 58% in
some areas. In Korea, the traffic share of the total PM2.5
exposure will be higher due to rapid urbanization. Traffic
air pollution will be great burden to urban air pollution
because if increasing car numbers in the near future.
Death attributed to air pollution will increase, if proper
countermeasures are not taken. If PM2,5 can be maintained
at less than 20 ug/m3 in 2024 in the Seoul metropolitan
area, death attributable to air pollution will decrease from
25,781 to 10,866. Korean people have a high disease
burden of cancer and chronic respiratory diseases, such
as asthma and COPD, attributed to air pollution. Clean
air strategies, such as the 2nd air management plan in
the Seoul metropolitan area, will decrease the burden of
disease in Korean people.
Even after accounting for the overall uncertainty of
this estimation, our study emphasizes the need to con-
sider air pollution as a pivotal cause of impaired health.
In a century moving toward a sustainable society, closer
collaboration of public health and environmental policies
will enable us to have preventive capacity. Further devel-
opment of standardized impact assessment methods is
needed in order to more stringently assess the benefits
from clean air strategies.
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